| Literature DB >> 27658732 |
Grant A Bateman1,2, Jeannette Lechner-Scott3,4,5, Rodney A Lea6.
Abstract
BACKGROUND: It has been suggested there is a chronic neurodegenerative disorder, underlying the pathophysiology of multiple sclerosis (MS), which is distinct from the more obvious immune-mediated attack on the white matter. Limited data exists indicating there is an alteration in pulse wave propagation within the craniospinal cavity in MS, similar to the findings in normal pressure hydrocephalus (NPH). It is hypothesized MS may harbor pulse wave encephalopathy. The purpose of this study is to compare blood flow and pulse wave measurements in MS patients with a cohort of NPH patients and control subjects, to test this hypothesis.Entities:
Keywords: Cerebral blood flow; Cerebrospinal fluid; Compliance; Multiple sclerosis; Normal pressure hydrocephalus; Pulse wave encephalopathy
Year: 2016 PMID: 27658732 PMCID: PMC5034419 DOI: 10.1186/s12987-016-0041-2
Source DB: PubMed Journal: Fluids Barriers CNS ISSN: 2045-8118
Demographics and clinical information for multiple sclerosis patients
| Patient number | Age (years) | Sex | Duration of disease (years) | Type | Treatment | ARCS | EDSS |
|---|---|---|---|---|---|---|---|
| 1 | 21 | F | 9 | RRMS | Natalizumab | 79 | 1.5 |
| 2 | 38 | F | 2 | RRMS | Interferon beta-1a | 100 | 0 |
| 3 | 57 | F | 4 | RRMS | Betaferon | 73 | 1.5 |
| 4 | 36 | F | 11 | RRMS | Natalizumab | 78 | 5.5 |
| 5 | 46 | F | 21 | RRMS | Natalizumab | 81 | 6.0 |
| 6 | 62 | F | 17 | RRMS | Nil | 72 | 6.5 |
| 7 | 40 | F | 16 | RRMS | Natalizumab | 82 | 1.5 |
| 8 | 51 | F | 26 | RRMS | Nil | 90 | 2.5 |
| 9 | 40 | F | 13 | RRMS | Natalizumab | 77 | 3.5 |
| 10 | 31 | F | 9 | RRMS | Natalizumab | 71 | 3.0 |
| 11 | 50 | F | 28 | RRMS | Nil | 96 | 2.5 |
| 12 | 36 | F | 4 | RRMS | Natalizumab | 83 | 1.0 |
| 13 | 46 | F | 4 | RRMS | Fingolimod | 86 | 1.5 |
| 14 | 59 | F | 22 | RRMS | Fingolimod | 60 | 1.5 |
| 15 | 36 | F | 4 | RRMS | Interferon beta-1a | 95 | 1.5 |
| 16 | 62 | F | 25 | RRMS | Glatiramer | 93 | 1.5 |
| 17 | 47 | F | 14 | RRMS | Betaferon | 92 | 1.0 |
| 18 | 31 | F | 9 | RRMS | Natalizumab | 79 | 1.5 |
| 19 | 28 | F | 11 | RRMS | Natalizumab | 93 | 1.5 |
| 20 | 48 | F | 5 | RRMS | Immunoglobulin | 111 | 3.5 |
ARCS audio recorded cognitive screen; EDSS extended disability status scale; F female; RRMS,relapsing remitting multiple sclerosis
Fig. 1A A FLAIR sagittal image of a 48 year old female MS patient with arrows showing some plaques within the corpus callosum but no significant cerebral volume loss. B A T2 sagittal image of the cervical spine in the same patient with arrows showing extensive MS plaques. C A sagittal post contrast T1 image with the black line showing the position of the venous acquisition passing through the sagittal sinus (large arrow) and straight sinus (small arrow). The white line is the arterial acquisition passing through the skull base. D The localizer image from the arterial acquisition showing the carotid arteries just above foramen lacerum (horizontal arrows) and the mid basilar artery (vertical arrow). E The phase image from the venous acquisition showing the sagittal sinus (large arrow) and straight sinus (small arrow). F The arterial flow graph from the same patient. The horizontal line represents the mean flow velocity. Where the mean velocity transects the flow graph is the start and end of systole. The grey area above the line represents the arterial stroke volume which for the three arteries combined was 1184 µL. The vertical line represents the midpoint of the two transection points and is the midpoint of the primary arterial wave i.e. 213 mS. G The sagittal sinus flow graph from the same patient. The horizontal line is the mean flow velocity. The grey area is the sinus stroke volume which is 118 µL or 10 % of the arterial stroke volume. The vertical line is the midpoint of the two transection points and is the center of the primary pulse wave i.e. 223 mS giving an AVD of 10 mS in this patient which is less than 10 % of normal indicating very low compliance
Brain blood flow in normal, multiple sclerosis and normal pressure hydrocephalus patients
| Age (years) | Arterial inflow (ml/min) | SSS outflow (ml/min) | ST outflow (ml/min) | %SSS | %ST | |
|---|---|---|---|---|---|---|
| Normal young n = 20 | ||||||
| Mean | 43 | 792 | 356 | 108 | 46 | 14 |
| SD | 16 | 142 | 76 | 29 | 8 | 3 |
| Normal elderly n = 12 | ||||||
| Mean | 70 | 709 | 310 | 91 | 44 | 13 |
| SD | 5 | 110 | 65 | 30 | 9 | 4 |
| | 0.0001* | NS | 0.03* | NS | NS | NS |
| Multiple sclerosis n = 20 | ||||||
| Mean | 43 | 783 | 311 | 95 | 41 | 12 |
| SD | 12 | 160 | 44 | 28 | 7 | 4 |
| | NS | NS | 0.01* | NS | 0.05* | NS |
| Normal pressure hydrocephalus n = 20 | ||||||
| Mean | 74 | 567 | 197 | 68 | 36 | 13 |
| SD | 7 | 148 | 49 | 24 | 9 | 5 |
| | NS | 0.02* | 0.0005* | 0.05* | 0.03* | NS |
SSS sagittal sinus sinus; ST straight sinus; %SSS percentage of arterial inflow drained by the SSS; %ST percentage of arterial inflow drained by ST; SD standard deviation; *t test p value <0.05; MS multiple sclerosis; NS not significant; NPH normal pressure hydrocephalus; NY normal young; NE normal elderly; p values are adjusted for age
AVD and pulsation stroke volume
| AVD (ms) | Arterial SV (µL) | SSS SV (µL) | ST SV (µL) | %SSS SV | %ST SV | |
|---|---|---|---|---|---|---|
| Normal young n = 20 | ||||||
| Mean | 112 | 914 | 273 | 73 | 31 | 8.7 |
| SD | 67 | 264 | 96 | 30 | 9 | 3.9 |
| Normal elderly n = 12 | ||||||
| Mean | 111 | 1331 | 308 | 71 | 23 | 5.6 |
| SD | 50 | 374 | 124 | 20 | 7 | 1.8 |
| | NS | 0.0006* | NS | NS | 0.02* | 0.02* |
| Multiple sclerosis n = 20 | ||||||
| Mean | 73 | 1152 | 188 | 50 | 16 | 4.4 |
| SD | 39 | 350 | 44 | 30 | 9 | 3.0 |
| | 0.02* | 0.02* | 0.007* | 0.02* | 0.0001* | 0.0003* |
| Hydrocephalus n = 20 | ||||||
| Mean | 47 | 963 | 170 | 42 | 19 | 4.4 |
| SD | 24 | 375 | 91 | 26 | 8 | 2.3 |
| | 0.0002* | 0.02* | 0.0005* | 0.002* | NS | NS |
AVD arteriovenous delay; ms milliseconds; SV stroke volume; SSS superior sagittal sinus; ST straight sinus; SD standard deviation; *t test p value <0.05; MS multiple sclerosis; NPH normal pressure hydrocephalus; NS not significant; NY normal young; NE normal elderly; p values are adjusted for age